Expression of Vascular Endothelial Growth Factor Receptor-3 in Non-small Cell Lung Cancer and Its Clinical Significance

张卫东,肖奇明,胡成平,陈琼
DOI: https://doi.org/10.3969/j.issn.1671-7171.2004.07.016
2004-01-01
Abstract:Objective To investigate the expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in tissues of non-small cell lung cancer.(NSCLC) and explore the relationship of VEGFR-3 to the different types, stage in tumor node metastasis (TNM) and prognosis of NSCLC.The expressions of VEGFR-3 in surgically resected tumor specimens collected from 50 cases with NSCLC and pulmonary inflammatory pseudotumor specimens from 20 cases served as controls were detected by immunohistochemical method.①The positive expression rate of VEGFR-3 in NSCLC (60%) was significantly higher than that in control group (10.0%)(P0.05). ②The elevation of positive VEGFR-3 expression accompanied the increase of TNM stage, there were statistical differences between I and Ⅲa stage(P0.05)as well as Ⅰ and Ⅲb stage of lung cancers(P0.05), also statistical difference was found between its Ⅱ and Ⅲb stage(P0.05). ③The NSCLC patients with positive expression of VEGFR-3 protein had a markedly shorter survival time than those with negative expression.[Conclusion]The expression of VEGFR-3 in tumor tissues of NSCLC is correlated with its TNM stage and prognosis. VEGFR-3 detection can be used as a criterion for evaluation of prognosis in NSCLC patients.
What problem does this paper attempt to address?